Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 6:50 PM View:  | Bvf Partners L P/il Director 10% Owner | Moonlake Immunotherapeutics (MLTX) | 04-Oct-24 | Private Sale | 2,000,000 | $50.00 | $100,003,000.00 | (9%) 21.69M to 19.69M | |
| 08-Oct-24 4:01 PM View: | Sturge Simon Director | Moonlake Immunotherapeutics (MLTX) | 04-Oct-24 | Private Sale | 171,000 | $53.72 | $9,186,120.00 | (50%) 342.98K to 171.98K | |
| 29-Feb-24 7:56 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 29-Feb-24 | Sale (Planned) | 4,740 | $55.89 | $264,919.00 | (< 1%) 2.99M to 2.98M | |
| 29-Feb-24 7:53 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 31,910 | $55.00 | $1,755,050.00 | (1%) 3.03M to 3.0M | |
| 29-Feb-24 7:56 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 56,065 | $55.00 | $3,083,580.00 | (2%) 3.04M to 2.99M | |
| 29-Feb-24 7:53 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 28,090 | $55.00 | $1,544,950.00 | (< 1%) 3.0M to 2.97M | |
| 29-Feb-24 7:53 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Sale (Planned) | 29,431 | $55.00 | $1,618,700.00 | (< 1%) 3.06M to 3.03M | |
| 29-Feb-24 7:56 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Private Sale (Planned) | 62,810 | $55.00 | $3,454,550.00 | (2%) 3.11M to 3.04M | |
| 29-Feb-24 7:53 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Private Sale (Planned) | 29,491 | $55.00 | $1,622,000.00 | (< 1%) 3.09M to 3.06M | |
| 22-Feb-24 6:32 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Sale (Planned) | 509 | $55.31 | $28,152.80 | (< 1%) 3.09M to 3.09M | |
| 22-Feb-24 6:32 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Sale (Planned) | 569 | $55.30 | $31,465.70 | (< 1%) 3.09M to 3.09M | |
| 23-Feb-24 4:48 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Private Sale (Planned) | 1,125 | $55.27 | $62,178.80 | (< 1%) 3.11M to 3.11M | |
| 22-Feb-24 6:32 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Private Sale (Planned) | 10,000 | $57.45 | $574,500.00 | (< 1%) 3.11M to 3.1M | |
| 20-Feb-24 6:36 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Sale (Planned) | 20,000 | $57.44 | $1,148,800.00 | (< 1%) 3.13M to 3.11M | |
| 22-Feb-24 6:32 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Sale (Planned) | 10,000 | $57.43 | $574,300.00 | (< 1%) 3.1M to 3.09M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 10,000 | $60.15 | $601,500.00 | (< 1%) 3.12M to 3.11M | |
| 20-Feb-24 6:36 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 20,000 | $60.15 | $1,203,000.00 | (< 1%) 3.15M to 3.13M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 10,000 | $60.15 | $601,500.00 | (< 1%) 3.13M to 3.12M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Sale (Planned) | 10,000 | $60.17 | $601,700.00 | (< 1%) 3.15M to 3.14M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Sale (Planned) | 10,000 | $60.16 | $601,600.00 | (< 1%) 3.14M to 3.13M | |
| 20-Feb-24 6:36 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Private Sale (Planned) | 20,000 | $60.18 | $1,203,600.00 | (< 1%) 3.17M to 3.15M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 14-Feb-24 | Private Sale (Planned) | 10,000 | $62.42 | $624,200.00 | (< 1%) 3.17M to 3.16M | |
| 16-Feb-24 6:02 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 14-Feb-24 | Sale (Planned) | 10,000 | $62.43 | $624,300.00 | (< 1%) 3.16M to 3.15M | |
| 21-Dec-23 4:01 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 20-Dec-23 | Sale (Planned) | 5,264 | $58.34 | $307,102.00 | (1%) 526.17K to 520.9K | |
| 21-Dec-23 4:01 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 19-Dec-23 | Private Sale (Planned) | 94,736 | $59.22 | $5,610,270.00 | (15%) 620.9K to 526.17K | |
| 10-Oct-23 4:00 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 05-Oct-23 | Purchase | 58,839 | $59.90 | $3,524,300.00 | < 1% 8.44M to 8.49M | |
| 04-Oct-23 5:52 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 04-Oct-23 | Purchase | 67,814 | $57.32 | $3,887,020.00 | < 1% 24.95M to 25.02M | |
| 04-Oct-23 5:52 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 03-Oct-23 | Purchase | 150,487 | $57.25 | $8,615,680.00 | < 1% 24.8M to 24.95M | |
| 04-Oct-23 5:52 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 02-Oct-23 | Purchase | 74,911 | $57.37 | $4,297,640.00 | < 1% 24.73M to 24.8M | |
| 03-Oct-23 10:00 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 41,981 | -- | -- | (1%) 3.41M to 3.36M | |
| 03-Oct-23 10:00 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 3,167,550 | -- | -- | 94% 3.38M to 6.55M | |
| 03-Oct-23 10:00 PM View: | Sturge Simon Director | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 342,980 | -- | -- | 100% 342.98K to 685.96K | |
| 03-Oct-23 10:00 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 2,527,480 | -- | -- | 75% 3.36M to 5.89M | |
| 03-Oct-23 10:00 PM View: | Santos da Silva Jorge Chief Executive Officer Director | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 3,167,550 | -- | -- | (48%) 6.55M to 3.38M | |
| 03-Oct-23 10:00 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 62,972 | -- | -- | (6%) 978.35K to 915.38K | |
| 03-Oct-23 10:00 PM View: | Sturge Simon Director | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 342,980 | -- | -- | (50%) 685.96K to 342.98K | |
| 03-Oct-23 10:00 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 41,981 | -- | -- | < 1% 5.89M to 5.93M | |
| 03-Oct-23 10:00 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 2,527,480 | -- | -- | (43%) 5.93M to 3.41M | |
| 03-Oct-23 10:00 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 62,972 | -- | -- | 7% 915.38K to 978.35K | |
| 05-Jul-23 4:05 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 30-Jun-23 | Purchase | 800,000 | $50.00 | $40,000,000.00 | 10% 7.8M to 8.6M | |
| 28-Jun-23 6:28 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 26-Jun-23 | Purchase | 450,000 | $45.63 | $20,535,000.00 | 6% 7.35M to 7.8M | |
| 07-Apr-23 4:05 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Disposition | 500,006 | -- | -- | (13%) 3.96M to 3.46M | |
| 07-Apr-23 4:05 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Disposition | 557,931 | -- | -- | (38%) 1.47M to 915.38K | |
| 07-Apr-23 4:05 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Disposition | 98,090 | -- | -- | (3%) 3.46M to 3.36M | |
| 07-Apr-23 4:05 PM View: | Bodenstedt Matthias Chief Financial Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Conversion | 557,931 | -- | -- | 61% 915.38K to 1.47M | |
| 07-Apr-23 4:05 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Conversion | 500,006 | -- | -- | 15% 3.36M to 3.86M | |
| 07-Apr-23 4:05 PM View: | Reich Kristian Chief Scientific Officer | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Conversion | 98,090 | -- | -- | 3% 3.86M to 3.96M | |
| 22-Mar-23 5:07 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 21-Mar-23 | Purchase | 238,511 | $21.70 | $5,176,000.00 | 4% 6.65M to 6.89M | |
| 22-Mar-23 5:07 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 20-Mar-23 | Purchase | 588,589 | $19.71 | $11,598,800.00 | 10% 6.07M to 6.65M | |
| 07-Apr-22 6:26 PM View: | Chen Bihua 10% Owner | Moonlake Immunotherapeutics (MLTX) | 05-Apr-22 | Conversion Duplicate | 2,785,000 | -- | -- | 648% 430.0K to 3.21M |
